In an article on INC42, few entrepreneurs chose to build their ventures in the lucrative sector of pharmaceuticals. One of the reasons that push entrepreneurs away from this industry is the fact that development of medicines requires a lot of time, energy, and capital. One entrepreneur who’s braced it all and made a lot of fortune in this industry is Jim Tananbaum.
Two and a half decades ago, Jim was your typical entrepreneur with grand plans of developing solutions to many people who suffer from various ailments. He harbored the idea of using technology to harness the future of healthcare. Jim threw all his weight and energy into the field of bio-pharmaceuticals having understood the key ingredients one needed to have a successful venture or company. A good team and constant innovation are some of the factors that set Jim’s enterprise on the road to success. That is how Foresite Capital was born.
According to Biz Journals, Foresite Capital is pioneering the future of healthcare. The enterprise has up to now invested in 77 unique medical services companies ranging from bio-pharmaceutical companies, diagnostics firms to genomic sequencing startups.
What fascinates Jim Tananbaum is the fact that entrepreneurs can leverage the science behind health care to come up with innovations and solutions that solve some of the man’s most intractable diseases and medical conditions. The future of medicine is ever quite exciting. Jim believes that in the future everyone will have their genome sequenced for the purpose of disease prevention and administration of more effective therapies. Jim is ready to be part of the professionals and business leaders who will champion this new kind of innovations in healthcare.
His glowing academic credentials are an inspiration to budding entrepreneurs. Jim’s thirst and passion for knowledge enable him to come up with the most efficient solutions to any medical challenge.
Many would say that Jim Tananbaum is overqualified academically. His undergraduate in math and electrical engineering is from the prestigious Yale College. Jim also holds an M.D. and an M.B.A from Harvard.